Retevmo medicine is recommended for the treatment of patients with metastatic RET fusion-positive non-small cell lung cancer, advanced or metastatic RET-mutant medullary thyroid cancer, and advanced or metastatic RET fusion-positive thyroid cancer. Retevmo capsules come in 40 mg and 80 mg for oral administration. The common side-effects of Retevmo are edema, diarrhea, fatigue, dry mouth, hypertension, abdominal pain, constipation, rash, nausea, and headache.
The price of Retevmo 40 mg and 80 mg is reasonable, and it is easily available from several pharmaceutical suppliers in India. To k ...
[retrieve this message]